A human hepatic mRNA analysis revealed that the expression of insulin receptor substrate (IRS)-2, which mediates the effects of insulin by acting as a molecular adopter, was decreased while that of gluconeogenesis enzymes was increased in both NAFL and NASH [19]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatohepatitis.